Intravenous Drug Use and Hepatitis C Virus in Iran

Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Intravenous Drug Use and Hepatitis C Virus in Iran Publisher

Zobeiri M¹ ; Adibi P² ; Alavian SM³

Source: Hepatitis Monthly Published:2012

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Intravenous Drug Use and Hepatitis C Virus in Iran, Hepatitis Monthly (2012)

2. Identification of Patients With Hepatitis C Virus Infection in Persons With Background of Intravenous Drug Use: The First Community Announcementbased Study From Iran, International Journal of Preventive Medicine (2012)

3. Isolation of Hepatitis C Virus in Norjizac Vials, Hepatitis Monthly (2010)

Experts (# of related papers)

View all Related Experts

Peyman Adibi (8)

Nazila Kassaian (7)

Other Related Docs

4. Seroprevalence of Hepatitis B Markers Among Incarcerated Intravenous Drug Users, Journal of Research in Medical Sciences (2014)

5. The Experience of Hepatitis C Screening Among Prison Inmates With Drug Injection History, Journal of Isfahan Medical School (2011)

6. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)

7. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)

8. Hepatitis C Virus in Iran: Epidemiology of an Emerging Infection, Archives of Iranian Medicine (2005)

9. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)

10. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)

11. Incarceration Is a Major Risk Factor for Blood-Borne Infection Among Intravenous Drug Users, Hepatitis Monthly (2011)

Style	Citing Format
MLA	Zobeiri M, Adibi P, Alavian SM. "Intravenous Drug Use and Hepatitis C Virus in Iran." Hepatitis Monthly, vol. 12, no. 1, 2012, pp. 9-10.
APA	Zobeiri M, Adibi P, Alavian SM (2012). Intravenous Drug Use and Hepatitis C Virus in Iran. Hepatitis Monthly, 12(1), 9-10.
Chicago	Zobeiri M, Adibi P, Alavian SM. "Intravenous Drug Use and Hepatitis C Virus in Iran." Hepatitis Monthly 12, no. 1 (2012): 9-10.
Harvard	Zobeiri M, Adibi P, Alavian SM (2012) 'Intravenous Drug Use and Hepatitis C Virus in Iran', Hepatitis Monthly, 12(1), pp. 9-10.
Vancouver	Zobeiri M, Adibi P, Alavian SM. Intravenous Drug Use and Hepatitis C Virus in Iran. Hepatitis Monthly. 2012;12(1):9-10.
BibTex	@article{ author = {Zobeiri M and Adibi P and Alavian SM}, title = {Intravenous Drug Use and Hepatitis C Virus in Iran}, journal = {Hepatitis Monthly}, volume = {12}, number = {1}, pages = {9-10}, year = {2012} }
RIS	TY - JOUR AU - Zobeiri M AU - Adibi P AU - Alavian SM TI - Intravenous Drug Use and Hepatitis C Virus in Iran JO - Hepatitis Monthly VL - 12 IS - 1 SP - 9 EP - 10 PY - 2012 ER -